Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 04:10:52 - browse：148

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： FDA seeks to regulate lab

hotspot

WSS

Covid vaccines: Private market messier than government rollout

How medical schools plan to diversify without affirmative action

Intercept Pharmaceuticals sells itself for less than $1 billion

White House touts steps to stem shortages of cancer treatments

What to make of Biden’s latest efforts on cancer research

IRA could hurt research into orphan drugs for rare diseases

Wikipedia

Wikipedia

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Affirmative action in medical school literally saved lives

FDA seeks to regulate lab

Trump demands the U.S. pay no more for drugs than other countries … again

FDA panel endorses Alnylam’s heart drug — after picking it apart

After affirmative action ruling, medical educators look to 'holistic review'

FDA panel endorses Alnylam’s heart drug — after picking it apart

ChatGPT in medicine: STAT answers readers' burning questions

Did you have Obamacare on your GOP debate bingo card?

Peter Hotez and the public health issue of online harassment

White House touts steps to stem shortages of cancer treatments

hotspot

FDA seeks to regulate lab

Diverse clinical trials: Why aren’t we there yet?

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Popular nasal decongestant doesn't actually relieve congestion

FDA seeks to regulate lab

What to make of Biden’s latest efforts on cancer research

Wikipedia

hotspot

explore

entertainment